The uncontrolled inflammatory host response against virus aggression, starting from airways colonization and infection, can produce a cytokine storm syndrome and IL-6 has been indicated as a key pathogenetic factor, thus representing a promising target of experimental biologic therapies in severe COVID-19 cases. This evidence concerns the gene IL6 and infection.